SONENDO INC (SONX) Stock Price, Forecast & Analysis

USA New York Stock Exchange NYSE:SONX • US8354311073

0.23 USD
-0.01 (-4.33%)
Last: Nov 21, 2023, 08:04 PM

SONX Key Statistics, Chart & Performance

Key Statistics
Market Cap12.48M
Revenue(TTM)44.40M
Net Income(TTM)-60.89M
Shares54.28M
Float45.65M
52 Week High2.95
52 Week Low0.21
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.65
PEN/A
Fwd PEN/A
Earnings (Next)03-09
IPO2021-10-29
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
SONX short term performance overview.The bars show the price performance of SONX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60 -80

SONX long term performance overview.The bars show the price performance of SONX in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of SONX is 0.23 USD. In the past year, price decreased by -90.3%.

SONENDO INC / SONX Daily stock chart

SONX Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

SONX Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to SONX. Both the profitability and financial health of SONX have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SONX Financial Highlights

Over the last trailing twelve months SONX reported a non-GAAP Earnings per Share(EPS) of -0.65. The EPS increased by 72.34% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -68.96%
ROE -161.08%
Debt/Equity 0.98
Chartmill High Growth Momentum
EPS Q2Q%70.21%
Sales Q2Q%5.69%
EPS 1Y (TTM)72.34%
Revenue 1Y (TTM)12.92%

SONX Forecast & Estimates

9 analysts have analysed SONX and the average price target is 1.75 USD. This implies a price increase of 659.46% is expected in the next year compared to the current price of 0.23.

For the next year, analysts expect an EPS growth of 65.53% and a revenue growth 8.44% for SONX


Analysts
Analysts80
Price Target1.75 (660.87%)
EPS Next Y65.53%
Revenue Next Year8.44%

SONX Ownership

Ownership
Inst Owners11.63%
Ins Owners24.26%
Short Float %0%
Short Ratio0

SONX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
ABT ABBOTT LABORATORIES19188.146B
ISRG INTUITIVE SURGICAL INC47.92169.625B
SYK STRYKER CORP24.04137.924B
BSX BOSTON SCIENTIFIC CORP22.24111.924B
BDX BECTON DICKINSON AND CO13.7359.33B
IDXX IDEXX LABORATORIES INC43.3851.339B
EW EDWARDS LIFESCIENCES CORP26.3946.291B
RMD RESMED INC21.7438.394B
GEHC GE HEALTHCARE TECHNOLOGY16.3837.64B
DXCM DEXCOM INC27.6827.621B

About SONX

Company Profile

SONX logo image Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 244 full-time employees. The company went IPO on 2021-10-29. The Company’s Product segment includes the sales of the GentleWave System console and related accessories and instruments. The GentleWave System, is a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. In addition to its GentleWave Console and single-use procedure instruments (PIs), it also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown, which facilitates an airtight seal between the PI and the tooth. The Company’s Software segment includes the sales of its software licenses for practice management software to enable an integrated digital office for endodontists.

Company Info

SONENDO INC

26061 Merit Circle, Suite 102

Laguna Hills CALIFORNIA US

CEO: Bjarne Bergheim

Employees: 244

SONX Company Website

Phone: 18447663636.0

SONENDO INC / SONX FAQ

Can you describe the business of SONENDO INC?

Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 244 full-time employees. The company went IPO on 2021-10-29. The Company’s Product segment includes the sales of the GentleWave System console and related accessories and instruments. The GentleWave System, is a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. In addition to its GentleWave Console and single-use procedure instruments (PIs), it also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown, which facilitates an airtight seal between the PI and the tooth. The Company’s Software segment includes the sales of its software licenses for practice management software to enable an integrated digital office for endodontists.


What is the stock price of SONENDO INC today?

The current stock price of SONX is 0.23 USD. The price decreased by -4.33% in the last trading session.


Does SONX stock pay dividends?

SONX does not pay a dividend.


What is the ChartMill technical and fundamental rating of SONX stock?

SONX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


Is SONENDO INC (SONX) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SONX.


What is the expected growth for SONX stock?

The Revenue of SONENDO INC (SONX) is expected to grow by 8.44% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.